Azitra, Inc. (AZTR)
USD 0.38
(-9.91%)
USD 0.38
(-9.91%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -54.76 USD | -5.55% |
| 2022 | -26.51 USD | -19.47% |
| 2021 | -22.19 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -2.74 USD | 37.13% |
| 2024 Q1 | -4.36 USD | 28.29% |
| 2023 Q3 | -4.82 USD | 56.1% |
| 2023 Q1 | -6.10 USD | -59.27% |
| 2023 FY | - USD | -5.55% |
| 2023 Q2 | -10.98 USD | -80.0% |
| 2023 Q4 | -6.08 USD | -26.14% |
| 2022 Q1 | -5.77 USD | 0.0% |
| 2022 FY | - USD | -19.47% |
| 2022 Q4 | -3.83 USD | -67.25% |
| 2022 Q2 | -4.69 USD | 18.72% |
| 2022 Q3 | -2.29 USD | 51.17% |
| 2021 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -0.60 USD | -9026.667% |
| Ampio Pharmaceuticals, Inc. | -10.67 USD | -413.215% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | -2767.016% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | -2892.35% |
| Can-Fite BioPharma Ltd. | -1.79 USD | -2959.218% |
| Chromocell Therapeutics Corporation | -1.28 USD | -4178.125% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | -3065.318% |
| CEL-SCI Corporation | -0.73 USD | -7401.37% |
| iBio, Inc. | -6.50 USD | -742.462% |
| Lineage Cell Therapeutics, Inc. | -0.12 USD | -45533.333% |
| MAIA Biotechnology, Inc. | -1.49 USD | -3575.168% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | -937.121% |
| Navidea Biopharmaceuticals, Inc. | -0.59 USD | -9181.356% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 60.505% |
| NanoViricides, Inc. | -0.70 USD | -7722.857% |
| Oragenics, Inc. | -9.18 USD | -496.514% |
| BiomX Inc. | -5.10 USD | -973.725% |
| BiomX Inc. | -5.10 USD | -973.725% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 45733.333% |
| Palatin Technologies, Inc. | -2.02 USD | -2610.891% |
| Scorpius Holdings, Inc. | -347.20 USD | 84.228% |